ULUR — Altrazeal Life Sciences Income Statement
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeMicro Cap
Annual income statement for Altrazeal Life Sciences, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2013 December 31st | 2014 December 31st | 2015 December 31st | 2016 December 31st | 2017 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 0.371 | 0.864 | 0.936 | 0.443 | 0.717 |
| Cost of Revenue | |||||
| Gross Profit | 0.148 | 0.352 | 0.664 | 0.415 | 0.487 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 3.02 | 2.7 | 3.38 | 4.74 | 2.23 |
| Operating Profit | -2.65 | -1.84 | -2.44 | -4.3 | -1.51 |
| Total Net Non Operating Interest Income / Expense | |||||
| Gain / Loss on Sale of Assets | |||||
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -3.08 | -1.94 | -2.7 | -4.45 | -1.94 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -3.08 | -1.94 | -2.7 | -4.45 | -1.94 |
| Net Income Before Extraordinary Items | |||||
| Net Income | -3.08 | -1.94 | -2.7 | -4.45 | -1.94 |
| Adjustments to Net Income | |||||
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Dilution Adjustment | |||||
| Diluted Net Income | -3.11 | -1.94 | -2.7 | -4.45 | -1.94 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -2.11 | -1.27 | -1.04 | -0.429 | -0.172 |
| Dividends per Share |